Dr. Hiroshi Tamura has been the owner/head of LPS (Laboratory Program Support) Consulting Office since February 2013. He provides business development consulting services in the field of microbial examination and endotoxin testing, harmonized USP, EP and JP regulations for pharmaceutical products, biotech-based drugs, and medical devices including on antimicrobial peptides and their practical use. He has also been engaged in the research and development of novel In Vitro Diagnostics (IVD) products approved by the FDA as well as Japan's Ministry of Health, Labor and Welfare (MHLW), based on clinical studies especially with regard to severe infectious diseases. These products were driven by innovative sensor technology for rapid detections of bacteria and fungi. He is also a Senior Advisor at Prop-Gene Inc., a company manufacturing test kits(infectious disease, human predisposition, food poisoning), biomedical equipments, environmental biotechnology and functional foods products, and also providing testing services (DNA sequence, gene analysis, biomarket tests etc.), since April 2012. In addition, Dr. Tamura serves as an Invited Associate Professor at the Department of Host Defense and Biochemical Research at the Juntendo University School of Medicine since April 2009 and has received a Visiting Research Fellowship from the Tokyo University of Pharmacy and Life Science. Prior to this, he was a Manager at SeikagakuBiobusiness Corporation from November 2007 to January 2012 and a Manager at the Seikagaku Corporation from April 1978 to October 2007. During this time, his team pioneered an advanced chromogenic Limulus amebocyte lysate (LAL) assay technology for bacterial endotoxin and (1,3)-beta-D-glucan and then paved the way for its standardized testing addressed in international pharmacopoeia and for more effective clinical diagnosis and treatment.
His research interests are in the areas of microbiology, immunology, host-pathogeninteraction, new technologies for rapid microbiological assay and functional diversity of host defense peptides.